139 related articles for article (PubMed ID: 18162511)
21. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
Egen JG; Kuhns MS; Allison JP
Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
[TBL] [Abstract][Full Text] [Related]
23. IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors.
Garapati VP; Lefranc MP
Dev Comp Immunol; 2007; 31(10):1050-72. PubMed ID: 17391759
[TBL] [Abstract][Full Text] [Related]
24. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.
Bhatia S; Edidin M; Almo SC; Nathenson SG
Immunol Lett; 2006 Apr; 104(1-2):70-5. PubMed ID: 16413062
[TBL] [Abstract][Full Text] [Related]
25. The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.
Wolchok JD; Saenger Y
Oncologist; 2008; 13 Suppl 4():2-9. PubMed ID: 19001145
[TBL] [Abstract][Full Text] [Related]
26. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
Wong SC; Tan AH; Lam KP
Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of T lymphocyte surface markers in children with chronic autoimmune thyroiditis.
Kucharska AM; Gorska E; Wasik M; Demkow U
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():375-82. PubMed ID: 19218661
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
29. B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up.
Chernyshov PV
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):656-9. PubMed ID: 19250325
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
Hueber AJ; Matzkies FG; Rahmeh M; Manger B; Kalden JR; Nagel T
Immunol Cell Biol; 2006 Feb; 84(1):51-8. PubMed ID: 16405652
[TBL] [Abstract][Full Text] [Related]
31. CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates.
Ma BY; Mikolajczak SA; Yoshida T; Yoshida R; Kelvin DJ; Ochi A
Biochem Biophys Res Commun; 2004 Apr; 317(1):60-7. PubMed ID: 15047148
[TBL] [Abstract][Full Text] [Related]
32. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
Liu Y; Yu Y; Yang S; Zeng B; Zhang Z; Jiao G; Zhang Y; Cai L; Yang R
Cancer Immunol Immunother; 2009 May; 58(5):687-97. PubMed ID: 18828017
[TBL] [Abstract][Full Text] [Related]
33. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
[TBL] [Abstract][Full Text] [Related]
34. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
Kondo T; Takata H; Matsuki F; Takiguchi M
J Immunol; 2009 Feb; 182(4):1794-8. PubMed ID: 19201830
[TBL] [Abstract][Full Text] [Related]
35. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.
Winslow BJ; Kalabat DY; Brown SM; Cochran MD; Collisson EW
Vet Microbiol; 2005 Nov; 111(1-2):1-13. PubMed ID: 16181751
[TBL] [Abstract][Full Text] [Related]
36. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
[TBL] [Abstract][Full Text] [Related]
37. The B7 family and cancer therapy: costimulation and coinhibition.
Zang X; Allison JP
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5271-9. PubMed ID: 17875755
[TBL] [Abstract][Full Text] [Related]
38. Synergistic costimulation by both B7 molecules regulates colitis pathogenesis.
Kim G; Schoenberger SP; Sharpe A; Kronenberg M
Ann N Y Acad Sci; 2006 Aug; 1072():233-41. PubMed ID: 17057203
[TBL] [Abstract][Full Text] [Related]
39. A divalent human leukocyte antigen-B7 fusion-protein up-regulates CD25 and CD69 in alloreactive CD8+ T cells bypassing CD28 costimulation.
Rickert U; Welke J; Behrens D; Zavazava N
Transplantation; 2006 May; 81(9):1337-44. PubMed ID: 16699464
[TBL] [Abstract][Full Text] [Related]
40. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response.
Hokey DA; Yan J; Hirao LA; Dai A; Boyer JD; Jure-Kunkel MN; Weiner DB
J Med Primatol; 2008 Dec; 37 Suppl 2():62-8. PubMed ID: 19187432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
